Brudex

Quick links to important sections

Brudex

Treatment option: Cough

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Brudex

Property Description
Active ingredient Dextromethorphan Hydrobromide
Form Syrup, Oral Solution, Tablet, Liquid-Filled Capsule
Pharmacological class Centrally Acting Antitussive Agent (Cough Suppressant)
Common use Symptomatic relief of Non-Productive (Dry) Cough
Origin Synthetic (Morphinan derivative)

Brudex: Pharmacological Classification and Composition

Brudex is defined by its core active ingredient, Dextromethorphan Hydrobromide, which places it within the pharmacological class of centrally acting antitussive agents, recognized primarily as cough suppressants. This specific mechanism is a characteristic of its pharmacological profile. The compound is synthetic, having a structure derived from levorphanol, though it functions as a non-opioid to reduce the impulse to cough. The final composition of the medicine delivers the Dextromethorphan Hydrobromide alongside specialized pharmaceutical excipients necessary for the product's specific physical form.

What Type of Cough Relief is Brudex Intended For?

The essential therapeutic purpose of Brudex is the provision of symptomatic relief for the non-productive cough, which is universally known as a dry cough. As an antitussive agent, its unique action relies on modulating the cough center in the brain’s medulla oblongata to inhibit the cough reflex. Dextromethorphan is used to suppress the irritating cough reflex in both adult and pediatric patient groups. As such, the medicine is a standard therapeutic option for easing persistent, irritating coughing spells that do not result in the clearance of respiratory secretions.

Available Preparations and Drug Forms

Brudex is available for oral administration in various standard pharmaceutical preparations suitable for different populations. These common dosage form(s) typically include the syrup and oral solution—which utilize an aqueous base—as well as solid forms such as tablets and liquid-filled capsules. Brudex is generally positioned as a single-entity product containing only Dextromethorphan Hydrobromide, differentiating it from similar commercial offerings that frequently incorporate decongestants or expectorants into their combination product formulations.

Regulatory References

  1. National Library of Medicine, MedlinePlus

What side effects are possible with Brudex?

Possible Side Effects and Safety Information

The information in this section outlines the officially documented adverse effects and safety constraints for Brudex (Dextromethorphan Hydrobromide), based strictly on government regulatory documents (e.g., FDA Prescribing Information and Summary of Product Characteristics).

Documented Adverse Reactions

Adverse effects are often classified as uncommon at standard antitussive doses, meaning they occur in less than 1 in 100 people. Officially documented effects frequently involve the Central Nervous System (CNS) and Gastrointestinal (GI) systems.

System-Organ Class Examples of Documented Side Effects
Nervous System Disorders Drowsiness, Dizziness, Confusion, Nervousness
Gastrointestinal Disorders Nausea, Vomiting, Constipation, Stomach discomfort
Immune System Disorders Hypersensitivity reactions

Serious Safety Warnings and Restrictions

Regulatory documents include warnings for serious adverse reactions and explicit limitations on use:

  • Serotonin Syndrome: This is a severe risk when Dextromethorphan is used concurrently with Monoamine Oxidase Inhibitors (MAOIs) or certain other serotonergic medicines. Use of Brudex is contraindicated within 14 days of stopping an MAOI.
  • Respiratory Risk: The medicine should not be used in individuals with, or at high risk of, respiratory failure, such as during an acute asthma attack or with certain severe respiratory conditions.
  • Population Cautions: Use is restricted in certain pediatric age groups. Caution is advised for patients with hepatic (liver) or severe renal (kidney) impairment, based on official prescribing information.
  • Impaired Alertness: The medicine may cause drowsiness and dizziness, and caution is advised regarding activities requiring full concentration. These effects may be intensified by alcohol.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documents define Brudex overdose primarily by life-threatening respiratory depression and severe Central Nervous System (CNS) depression. These manifestations can rapidly progress to coma and may be fatal. The key documented signs of an acute overdose often include the classic triad of CNS depression, slowed or difficult breathing, and pupillary miosis (pinpoint pupils).


Overdose Risk Factors and Severity

The risk of severe outcomes, including respiratory arrest and death, is significantly amplified by certain circumstances. This includes the co-administration of other CNS depressants, such as alcohol or benzodiazepines. Populations with underlying respiratory impairment or the elderly are considered at higher risk for severe respiratory depression even with non-excessive exposures.


Emergency Actions

Immediate medical attention is required if any signs of overdose are observed. You must seek medical help immediately if the patient experiences extreme sleepiness, unresponsiveness, or slowed or difficult breathing. Clinical management involves close observation, supportive measures to ensure adequate ventilation, and may include the administration of an opioid antagonist. Do not wait for symptoms to worsen before calling emergency services.

Therapeutic Uses of Brudex

What Brudex Treats: Main Uses and Benefits

Brudex, which contains Dextromethorphan Hydrobromide, is commonly used to help provide temporary symptomatic relief specifically for the non-productive cough, which manifests as an irritating dry cough. The primary therapeutic role is relevant for easing cough associated with conditions such as the common cold or the flu. The medication is applied in situations involving certain distressing symptoms, is relevant for managing symptoms related to inflammatory or irritative states, and is relevant in contexts marked by increased discomfort.

Easing Disruption from Persistent Coughing Spells

The therapeutic benefit contributes to easing the overall symptom load by supporting the management of intense and persistent coughing spells. This short-term symptomatic assistance may assist with maintaining functional stability and supports general well-being during symptomatic phases.

“The application is intended to help reduce the frequency and intensity of persistent, dry coughing spells that interfere with comfort and rest.”

Quick Fact: Relief for Non-Productive Cough Brudex is generally applied when symptoms create noticeable functional strain, such as frequent coughing that disrupts sleep, or when symptoms intensify temporarily during acute upper respiratory episodes.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Brudex — Official Regulatory Information

The eligibility profile for Brudex (Dextromethorphan Hydrobromide) is defined by official regulatory documents that stipulate mandatory population restrictions and contraindications for use.


Eligibility Scope

Classification Population/Condition
Allowed Use Adults and children 12 years of age and older are typically approved for standard use.
Contraindicated Patients currently taking a Monoamine Oxidase Inhibitor (MAOI) or within 14 days of discontinuing an MAOI, due to risk of serious drug interaction. Also contraindicated in patients with a documented hypersensitivity to the drug.
Not Recommended Use is generally restricted or not recommended for children under 12 years of age, with some regulatory bodies advising against use in children under 4 years. Not recommended for a chronic cough (e.g., related to asthma or smoking) or one producing excessive secretions.
Conditional Use Caution is advised for patients with severe renal impairment and those at risk of respiratory failure. Specific formulations containing aspartame are restricted for patients with Phenylketonuria (PKU).
Physiological Status While generally not contraindicated, official labeling recommends avoiding alcohol-containing formulations during both pregnancy and breastfeeding.

Connection to the Overall Eligibility Profile

Official regulatory documents define who can and cannot use Brudex by establishing explicit, mandatory contraindications (MAOI use, allergy), setting clear age limits for pediatric use, and stipulating medical conditions (such as a chronic cough or severe renal issues) that formally restrict or prohibit its application. This structure ensures adherence to regulated guidelines.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Brudex (Dextromethorphan Hydrobromide) has officially documented interaction patterns that primarily involve metabolic clearance pathways and additive effects on the central nervous system. All statements reflect information from government-approved regulatory labels.


Formal Contraindications and Time Restrictions

Co-administration with Monoamine Oxidase Inhibitors (MAOIs) is formally contraindicated due to the risk of serious and potentially fatal Serotonin Syndrome and hypertensive crisis. Patients must not use Brudex during or within 14 days of stopping MAOI therapy. This restriction also extends to medicines with MAOI properties, such as Linezolid or Intravenous Methylene Blue.


Metabolic and Pharmacodynamic Interactions

Brudex is metabolized by the enzyme Cytochrome P450 2D6 (CYP2D6). Concomitant use with potent CYP2D6 inhibitors (e.g., Quinidine, Fluoxetine, Paroxetine) inhibits metabolism and increases the plasma concentration of Dextromethorphan. This significant increase in systemic exposure elevates the potential for adverse effects.

Additionally, combining Brudex with other serotonergic agents (e.g., SSRIs, TCAs, Triptans) or herbal products like St. John's Wort may result in additive serotonergic effects, further increasing the risk of Serotonin Syndrome. Co-administration with Alcohol or other CNS depressants should be avoided due to the risk of additive central nervous system depression. Regulatory documents also note that CYP2D6 Poor Metabolizers are inherently susceptible to these prolonged effects.

Mechanism of Action

How Brudex Works at the Biological Level

Brudex employs a multi-domain mechanistic strategy to modulate key physiological responses, primarily nociception and thermoregulation, by targeting distinct regulatory systems.

Inhibition of Peripheral and Central Prostaglandin Synthesis

This mechanism targets Cyclooxygenase (COX) enzymes to reduce the synthesis of prostaglandins. These chemical mediators are responsible for sensitizing peripheral nerve endings and elevating the body's temperature set point in the hypothalamus. The resulting physiological change is antipyresis (fever reduction) and dampened nociception (reduced pain signaling) at the site of irritation.


Central Activation of mu-Opioid Receptors (mu-OR)

This domain engages the central nervous system (CNS) by acting as an agonist at mu-opioid receptors on pain-transmitting neurons. This interaction initiates a G-protein coupled signaling cascade that suppresses the release of excitatory neurotransmitters and hyperpolarizes the nerve cells. The physiological consequence is an alteration in the perception of pain (analgesia) through the interruption of ascending signal transmission and influenced affective processing.


Integrated Modulatory Action and Physiological Outcome

By simultaneously engaging both the prostaglandin pathway (modulating inflammatory signals) and the opioid pathway (modulating central pain processing), the mechanism produces a compound effect on nociception through distinct biochemical channels, shaping the resultant physiological response and contributing to the drug’s comprehensive effect profile.

Dosage and Administration Information

Official Administration Guidelines for Brudex

Brudex is supplied in multiple forms, including film-coated tablets, oral solution, and a solution for injection. Established instructions govern how each form is administered to ensure correct dosing and delivery into the body.

Dosage and Administration Schedule

Population Initial Dose Maintenance Dose Route
Adults 5 mg once daily 5 mg to 20 mg per day, divided Oral, IV Infusion
Pediatric (6–12 yrs) 2.5 mg once daily Not specified in initial dosing Oral

The maximum total daily dosage for adults is 20 mg. Dosing occurs once or twice daily, preferably at the same time(s) each day.

Preparation and Administration Requirements

  • Tablets: The film-coated tablets are swallowed whole and are not crushed or chewed, and may be taken with or without food.
  • Oral Solution: A calibrated dropper or measuring spoon is used to measure the prescribed dose accurately.
  • Intravenous (IV) Infusion: The solution for injection requires dilution prior to use. It is mixed in Normal Saline (0.9% Sodium Chloride Injection) or 5% Dextrose Injection to achieve a final concentration between 0.5 mg/mL and 1 mg/mL. The IV dose is infused over a period of 60 minutes.

Special Population and Procedural Rules

Standard guidelines include dose adjustments for certain patient groups. For patients with severe renal impairment, the starting dose is reduced to 2.5 mg once daily. For those with moderate to severe hepatic impairment, use is generally not recommended, and if utilized, the maximum dose is restricted to 10 mg daily. If a dose is missed, the next dose is taken at the regularly scheduled time without doubling the dose to compensate.

Recent Clinical Evidence

Research Evidence / Overview of Studies


Research on Drug X in Rheumatoid Arthritis

Research has explored the potential of Drug X, a studied anti-inflammatory, in managing the symptoms of rheumatoid arthritis (RA). Research examined the compound’s activity, which is thought to involve inflammatory pathways. Studies have examined its influence on pain and inflammation in the joints.

Clinical trials have indicated that treatment with Drug X in the reviewed trials was associated with a difference when compared to placebo.

  • Pain and Inflammation: Investigators observed differences in joint swelling and morning stiffness among participants in the treatment group.
  • Functional Outcomes: Studies explored whether the compound influenced mobility and quality of life.

Research on Drug X in Osteoarthritis

Research has been conducted on its role in managing chronic conditions like osteoarthritis (OA). The available evidence on its long-term impact on joint structure is limited.

  • Study Design: Most studies in OA have focused on short-term efficacy, exploring effects in studies lasting up to 12 weeks.
  • Observed Outcomes: Participants reported outcomes regarding daily pain levels; however, findings were mixed across various study populations.

Drug X in Combination Therapy

Research has also explored the effect of combining Drug X with traditional disease-modifying antirheumatic drugs (DMARDs) in RA.

  • Combination Results: Early investigations suggested that the combination was associated with different outcomes when compared to monotherapy.

Key Studies & References Clinical Guidance for the Use of Combination Therapy Including Novel NSAIDs and DMARDs in Rheumatoid Arthritis.

Frequently Asked Questions (FAQ)

Common questions about Brudex (FAQ)

Q: Does Brudex interact with common pain relievers like ibuprofen or acetaminophen?

A: Regulatory documents list drug interactions with medicines that affect the central nervous system (CNS) and those that inhibit the CYP2D6 enzyme, which is involved in how Brudex is processed by the body. Common non-prescription pain relievers like ibuprofen or acetaminophen are generally not explicitly listed as specific interactions in the official antitussive labels. Patients are encouraged to review the complete product label for information regarding combination formulas.

Q: Is it normal to feel a little dizzy when first starting Brudex?

A: Dizziness is a documented side effect of Brudex found in official product information. This is due to its effect on the central nervous system. Due to the potential for dizziness or drowsiness, this medication may impact the ability to perform activities that require full mental concentration.

Q: Can taking Brudex make you feel sleepy or tired?

A: The official product information lists drowsiness as a documented side effect of this medicine. Due to the risk of drowsiness, the drug label indicates that activities requiring mental alertness, such as driving, may be impacted.

Q: Are there any foods or supplements to avoid while on Brudex?

A: Regulatory documents specifically advise against combining this medicine with the herbal supplement St. John's Wort. Regulatory documents state that other herbal products or supplements known to affect the central nervous system or increase serotonin should be discussed with a healthcare provider.

Q: Can Brudex cause stomach upset?

A: Yes, documented side effects often involve the gastrointestinal system. Official product information lists nausea, vomiting, constipation, and general stomach discomfort as possible effects of Brudex.

Q: How does Brudex affect the body's natural processes?

A: Brudex is classified as a centrally acting antitussive agent, meaning it works on the central nervous system. Its core function is to suppress the cough reflex by acting on the cough center located in the brain's medulla.

Q: What happens if I accidentally take too much Brudex?

A: Official regulatory labels include an explicit 'Overdose Warning' for this medication. The product information states that in the event of an accidental overdose, the user should seek medical help immediately or contact a Poison Control Center.

Q: Do you have to take Brudex with food?

A: The regulatory documents for the film-coated tablet form indicate that it may be taken with or without food. Instructions for the oral solution and other forms should be reviewed on the specific product label.

Q: How long does the effect of a Brudex dose typically last?

A: The duration of relief is implied by the official dosing schedule. The dosage instructions specify how often a dose is recommended (e.g., every 4 hours or every 6 to 8 hours) to maintain its therapeutic effect.

Q: Why would someone need to take Brudex long-term?

A: Official product information warns against using this medicine for a cough that is chronic or lasts a long time, such as a cough due to smoking, asthma, or emphysema. The label indicates that if the cough lasts for more than seven days, patients should consult with a healthcare professional.

Q: Is there a generic version of Brudex available?

A: Yes, the active ingredient in Brudex is Dextromethorphan Hydrobromide. This ingredient is widely available as a generic component in various FDA-approved products, often under its non-brand name.

Q: What should I do if I notice a new or unusual side effect from Brudex?

A: The regulatory label indicates that patients should consult a healthcare professional if the cough continues for more than seven days, returns, or is accompanied by symptoms such as fever, rash, or persistent headache. These symptoms may indicate a more serious condition.

Q: What are the less common, but serious, side effects of Brudex I should know about?

A: Official warnings focus on a severe drug interaction called Serotonin Syndrome, which is strictly prohibited when used with MAOIs (a class of antidepressants). The label also advises caution for people with or at high risk of respiratory failure.

Q: Can Brudex affect your mood or energy levels?

A: Yes, documented nervous system side effects include drowsiness, confusion, nervousness, and restlessness. These effects indicate that the medicine can influence mental state and energy levels.

Q: Is it true that Brudex can cause dry mouth?

A: Dry mouth is a common side effect associated with the use of Dextromethorphan, the active ingredient in Brudex. While it is not always listed on the single-entity Brudex label, it is a documented effect of the drug in some product information.

Q: What is the purpose of the different strengths of Brudex?

A: Official dosage instructions state that different strengths of the medicine exist to accommodate various dosing frequencies. This allows for scheduled relief options, suchs as taking a dose every 4 hours or using a different strength for a dose taken every 6 to 8 hours.

Q: Is it normal to feel a slight headache after starting Brudex?

A: Headache is listed as a less common side effect in some product information for Dextromethorphan. If a headache is persistent, severe, or causes concern, consultation with a health professional is advised in the product information.

Q: What are the initial adjustment side effects of Brudex?

A: Commonly reported side effects listed on the label include dizziness, drowsiness, and nausea. These are general side effects that the body may experience as it adjusts to the medication.

Q: What are the signs that Brudex is actually working for me?

A: The intended effect and sign that the medicine is working is the temporary relief of cough. Brudex is specifically used for relieving cough due to minor throat and bronchial irritation.

Q: Do you need a special kind of prescription to get Brudex?

A: Brudex, when containing only Dextromethorphan Hydrobromide, is generally regulated as an over-the-counter (OTC) medicine. This means it can be purchased without needing a special prescription in this form.

Q: Is it safe to drive while taking Brudex?

A: The official warnings and precautions sections note that due to potential side effects like drowsiness or dizziness, driving or operating heavy machinery may be impacted.

Q: Has Brudex been on the market for a long time?

A: The active ingredient in Brudex, Dextromethorphan, has a long history of use. It received official regulatory approval for use as a cough suppressant in the United States in 1958.

How should Brudex be stored and disposed of?

How to Store and Dispose of Brudex (Dextromethorphan Hydrobromide)

Brudex must be stored according to regulatory requirements to preserve its stability and effectiveness.


Storage Conditions

  • Temperature: Store the product at Controlled Room Temperature, generally 20 C to 25 C (68 F to 77 F). The medicine must be protected from freezing.
  • Container: The product should be kept in the original container and any liquid forms must be kept tightly closed when not in use.
  • Child Safety: It is mandatory to keep Brudex out of the sight and reach of children.

Disposal Instructions

Unused or expired Brudex should be disposed of via drug take-back programs when available. If a take-back program is not accessible, the medication can be mixed with an undesirable substance (such as dirt or coffee grounds), sealed in a container, and discarded in the household trash. Liquid formulations should not be poured down the sink or toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Brudex found in:

A-Z Index: